Act prioritizes fight against Alzheimer’s disease with state plan
By
Kimberly Bonvissuto
Sep 12, 2023
South Carolina’s adoption of a state Alzheimer’s plan is a “step forward,” according to senior living advocates.
Certain types of air pollution raise risk of dementia: study
By
Kimberly Bonvissuto
Aug 22, 2023
The risk of dementia is greater among people in regions of the US with high levels of a certain type of air pollution, particularly from agriculture and wildfires, according to a new study published in...
CMS dementia care pilot program to expand care delivery options
By
Kimberly Bonvissuto
Aug 01, 2023
Assisted living residents may be part of a new Medicare dementia care model that will test an alternative payment for family caregivers while expanding care delivery options to allow people living with...
Package of bills targets memory care services, staffing agency regulation
By
Kimberly Bonvissuto
Jun 06, 2023
Delaware lawmakers took the recommendations from a recently released long-term care task force report to heart in introducing a package of bills that target dementia care and temporary staffing agency...
Rosalynn Carter’s dementia news ‘will increase important conversations’ about disease, family hopes
By
Kimberly Bonvissuto
May 31, 2023
Sharing the news that former first lady Rosalynn Carter has dementia will “increase important conversations at kitchen tables and in doctor’s offices around the country,” the Carter family hoped...
$215,000 disability discrimination complaint could have ‘broader ramifications’ on resident contracts,...
By
Kimberly Bonvissuto
Apr 12, 2023
A Pennsylvania continuing care retirement community agreed to a $215,000 Fair Housing Act settlement over allegations of disability discrimination, but the senior living owners and operators said that...
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
Living with others, being engaged slow cognitive decline: study
By
Kimberly Bonvissuto
Oct 27, 2022
Living with others, weekly community group engagement and interaction with family and friends, and never feeling lonely are associated with slower cognitive decline, according to the results of a new study.